Enhancement of antibiotic activity by efflux inhibitors against multidrug resistant mycobacterium tuberculosis clinical isolates from Brazil
Autor(a) principal: | |
---|---|
Data de Publicação: | 2015 |
Outros Autores: | , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da FURG (RI FURG) |
Texto Completo: | http://repositorio.furg.br/handle/1/7019 |
Resumo: | Drug resistant tuberculosis continues to increase and new approaches for its treatment are necessary. The identification of M. tuberculosis clinical isolates presenting efflux as part of their resistant phenotype has a major impact in tuberculosis treatment. In this work, we used a checkerboard procedure combined with the tetrazolium microplate-based assay (TEMA) to study single combinations between antituberculosis drugs and efflux inhibitors (EIs) against multidrug resistant M. tuberculosis clinical isolates using the fully susceptible strain H37Rv as reference. Efflux activity was studied on a real-time basis by a fluorometric method that uses ethidium bromide as efflux substrate. Quantification of efflux pump genes mRNA transcriptional levels were performed by RT-qPCR. The fractional inhibitory concentrations (FIC) indicated synergistic activity for the interactions between isoniazid, rifampicin, amikacin, ofloxacin, and ethidium bromide plus the EIs verapamil, thioridazine and chlorpromazine. The FICs ranged from 0.25, indicating a four-fold reduction on the MICs, to 0.015, 64-fold reduction. The detection of active efflux by real-time fluorometry showed that all strains presented intrinsic efflux activity that contributes to the overall resistance which can be inhibited in the presence of the EIs. The quantification of the mRNA levels of the most important efflux pump genes on these strains shows that they are intrinsically predisposed to expel toxic compounds as the exposure to subinhibitory concentrations of antibiotics were not necessary to increase the pump mRNA levels when compared with the non-exposed counterpart. The results obtained in this study confirm that the intrinsic efflux activity contributes to the overall resistance in multidrug resistant clinical isolates of M. tuberculosis and that the inhibition of efflux pumps by the EIs can enhance the clinical effect of antibiotics that are their substrates. |
id |
FURG_3dec4297f0400ba67d9d22cb81ced606 |
---|---|
oai_identifier_str |
oai:repositorio.furg.br:1/7019 |
network_acronym_str |
FURG |
network_name_str |
Repositório Institucional da FURG (RI FURG) |
repository_id_str |
|
spelling |
Enhancement of antibiotic activity by efflux inhibitors against multidrug resistant mycobacterium tuberculosis clinical isolates from BrazilTuberculosisDrug resistanceFluorometryCheckerboardTEMAFractional inhibitory concentrationDrug resistant tuberculosis continues to increase and new approaches for its treatment are necessary. The identification of M. tuberculosis clinical isolates presenting efflux as part of their resistant phenotype has a major impact in tuberculosis treatment. In this work, we used a checkerboard procedure combined with the tetrazolium microplate-based assay (TEMA) to study single combinations between antituberculosis drugs and efflux inhibitors (EIs) against multidrug resistant M. tuberculosis clinical isolates using the fully susceptible strain H37Rv as reference. Efflux activity was studied on a real-time basis by a fluorometric method that uses ethidium bromide as efflux substrate. Quantification of efflux pump genes mRNA transcriptional levels were performed by RT-qPCR. The fractional inhibitory concentrations (FIC) indicated synergistic activity for the interactions between isoniazid, rifampicin, amikacin, ofloxacin, and ethidium bromide plus the EIs verapamil, thioridazine and chlorpromazine. The FICs ranged from 0.25, indicating a four-fold reduction on the MICs, to 0.015, 64-fold reduction. The detection of active efflux by real-time fluorometry showed that all strains presented intrinsic efflux activity that contributes to the overall resistance which can be inhibited in the presence of the EIs. The quantification of the mRNA levels of the most important efflux pump genes on these strains shows that they are intrinsically predisposed to expel toxic compounds as the exposure to subinhibitory concentrations of antibiotics were not necessary to increase the pump mRNA levels when compared with the non-exposed counterpart. The results obtained in this study confirm that the intrinsic efflux activity contributes to the overall resistance in multidrug resistant clinical isolates of M. tuberculosis and that the inhibition of efflux pumps by the EIs can enhance the clinical effect of antibiotics that are their substrates.2017-01-15T20:13:05Z2017-01-15T20:13:05Z2015info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfCOELHO, Tatiane Silveira; et al. Enhancement of antibiotic activity by efflux inhibitors against multidrug resistant mycobacterium tuberculosis clinical isolates from Brazil. Frontiers in Microbiology. V. 6, p. 330, 2015. Disponível em: <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4412083/pdf/fmicb-06-00330.pdf>.Acesso em: 13 jan. 2017.http://repositorio.furg.br/handle/1/7019doi: 10.3389/fmicb.2015.00330engCoelho, Tatiane SilveiraMachado, DianaCouto, IsabelMaschmann, Raquel AbreuSoares, Daniela Fernandes RamosGroll, Andrea VonRossetti, Maria Lucia RosaSilva, Pedro Almeida daViveiros, Miguelinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da FURG (RI FURG)instname:Universidade Federal do Rio Grande (FURG)instacron:FURG2022-10-21T21:59:54Zoai:repositorio.furg.br:1/7019Repositório InstitucionalPUBhttps://repositorio.furg.br/oai/request || http://200.19.254.174/oai/requestopendoar:2022-10-21T21:59:54Repositório Institucional da FURG (RI FURG) - Universidade Federal do Rio Grande (FURG)false |
dc.title.none.fl_str_mv |
Enhancement of antibiotic activity by efflux inhibitors against multidrug resistant mycobacterium tuberculosis clinical isolates from Brazil |
title |
Enhancement of antibiotic activity by efflux inhibitors against multidrug resistant mycobacterium tuberculosis clinical isolates from Brazil |
spellingShingle |
Enhancement of antibiotic activity by efflux inhibitors against multidrug resistant mycobacterium tuberculosis clinical isolates from Brazil Coelho, Tatiane Silveira Tuberculosis Drug resistance Fluorometry Checkerboard TEMA Fractional inhibitory concentration |
title_short |
Enhancement of antibiotic activity by efflux inhibitors against multidrug resistant mycobacterium tuberculosis clinical isolates from Brazil |
title_full |
Enhancement of antibiotic activity by efflux inhibitors against multidrug resistant mycobacterium tuberculosis clinical isolates from Brazil |
title_fullStr |
Enhancement of antibiotic activity by efflux inhibitors against multidrug resistant mycobacterium tuberculosis clinical isolates from Brazil |
title_full_unstemmed |
Enhancement of antibiotic activity by efflux inhibitors against multidrug resistant mycobacterium tuberculosis clinical isolates from Brazil |
title_sort |
Enhancement of antibiotic activity by efflux inhibitors against multidrug resistant mycobacterium tuberculosis clinical isolates from Brazil |
author |
Coelho, Tatiane Silveira |
author_facet |
Coelho, Tatiane Silveira Machado, Diana Couto, Isabel Maschmann, Raquel Abreu Soares, Daniela Fernandes Ramos Groll, Andrea Von Rossetti, Maria Lucia Rosa Silva, Pedro Almeida da Viveiros, Miguel |
author_role |
author |
author2 |
Machado, Diana Couto, Isabel Maschmann, Raquel Abreu Soares, Daniela Fernandes Ramos Groll, Andrea Von Rossetti, Maria Lucia Rosa Silva, Pedro Almeida da Viveiros, Miguel |
author2_role |
author author author author author author author author |
dc.contributor.author.fl_str_mv |
Coelho, Tatiane Silveira Machado, Diana Couto, Isabel Maschmann, Raquel Abreu Soares, Daniela Fernandes Ramos Groll, Andrea Von Rossetti, Maria Lucia Rosa Silva, Pedro Almeida da Viveiros, Miguel |
dc.subject.por.fl_str_mv |
Tuberculosis Drug resistance Fluorometry Checkerboard TEMA Fractional inhibitory concentration |
topic |
Tuberculosis Drug resistance Fluorometry Checkerboard TEMA Fractional inhibitory concentration |
description |
Drug resistant tuberculosis continues to increase and new approaches for its treatment are necessary. The identification of M. tuberculosis clinical isolates presenting efflux as part of their resistant phenotype has a major impact in tuberculosis treatment. In this work, we used a checkerboard procedure combined with the tetrazolium microplate-based assay (TEMA) to study single combinations between antituberculosis drugs and efflux inhibitors (EIs) against multidrug resistant M. tuberculosis clinical isolates using the fully susceptible strain H37Rv as reference. Efflux activity was studied on a real-time basis by a fluorometric method that uses ethidium bromide as efflux substrate. Quantification of efflux pump genes mRNA transcriptional levels were performed by RT-qPCR. The fractional inhibitory concentrations (FIC) indicated synergistic activity for the interactions between isoniazid, rifampicin, amikacin, ofloxacin, and ethidium bromide plus the EIs verapamil, thioridazine and chlorpromazine. The FICs ranged from 0.25, indicating a four-fold reduction on the MICs, to 0.015, 64-fold reduction. The detection of active efflux by real-time fluorometry showed that all strains presented intrinsic efflux activity that contributes to the overall resistance which can be inhibited in the presence of the EIs. The quantification of the mRNA levels of the most important efflux pump genes on these strains shows that they are intrinsically predisposed to expel toxic compounds as the exposure to subinhibitory concentrations of antibiotics were not necessary to increase the pump mRNA levels when compared with the non-exposed counterpart. The results obtained in this study confirm that the intrinsic efflux activity contributes to the overall resistance in multidrug resistant clinical isolates of M. tuberculosis and that the inhibition of efflux pumps by the EIs can enhance the clinical effect of antibiotics that are their substrates. |
publishDate |
2015 |
dc.date.none.fl_str_mv |
2015 2017-01-15T20:13:05Z 2017-01-15T20:13:05Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
COELHO, Tatiane Silveira; et al. Enhancement of antibiotic activity by efflux inhibitors against multidrug resistant mycobacterium tuberculosis clinical isolates from Brazil. Frontiers in Microbiology. V. 6, p. 330, 2015. Disponível em: <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4412083/pdf/fmicb-06-00330.pdf>.Acesso em: 13 jan. 2017. http://repositorio.furg.br/handle/1/7019 doi: 10.3389/fmicb.2015.00330 |
identifier_str_mv |
COELHO, Tatiane Silveira; et al. Enhancement of antibiotic activity by efflux inhibitors against multidrug resistant mycobacterium tuberculosis clinical isolates from Brazil. Frontiers in Microbiology. V. 6, p. 330, 2015. Disponível em: <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4412083/pdf/fmicb-06-00330.pdf>.Acesso em: 13 jan. 2017. doi: 10.3389/fmicb.2015.00330 |
url |
http://repositorio.furg.br/handle/1/7019 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da FURG (RI FURG) instname:Universidade Federal do Rio Grande (FURG) instacron:FURG |
instname_str |
Universidade Federal do Rio Grande (FURG) |
instacron_str |
FURG |
institution |
FURG |
reponame_str |
Repositório Institucional da FURG (RI FURG) |
collection |
Repositório Institucional da FURG (RI FURG) |
repository.name.fl_str_mv |
Repositório Institucional da FURG (RI FURG) - Universidade Federal do Rio Grande (FURG) |
repository.mail.fl_str_mv |
|
_version_ |
1813187244508315648 |